Proton pump inhibitors and antibiotics adversely effect the efficacy of nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
2023 · European Journal of Cancer · 15 citations
https://doi.org/10.1016/j.ejca.2023.02.011